Doctor of Philosophy by Pioli, Peter Dion
MODULATION OF LYMPHOCYTE DEVELOPMENT AND FUNCTION VIA  
 














A dissertation submitted to the faculty of 
The University of Utah 
















Department of Pathology 
 





















Copyright © Peter Dion Pioli 2015 
 
All Rights Reserved 
 








The dissertation of Peter Dion Pioli 
has been approved by the following supervisory committee members: 
 
John Weis , Chair 03/02/2015 
 
Date Approved 
Srividya Bhaskara , Member 03/02/2015 
 
Date Approved 
Xinjian Chen , Member 03/02/2015 
 
Date Approved 
Gerald Spangrude , Member 03/02/2015 
 
Date Approved 




and by Peter Jensen , Chair/Dean of  
the 
Department/College/School of Pathology 
 








Antigen receptor-encoding lymphocytes (i.e., B and T cells) are key  
 
mediators of the adaptive immune response.  Hence, the developmental and  
 
functional programs of these cells are crucial to the sustained viability of  
 
metazoans such as mouse and man.  One strategy to ensure these cellular  
 
programs is through the use of tightly orchestrated networks of gene expression.   
 
To preserve these networks, a myriad of proteins function to activate or repress  
 
particular sets of genes. 
 
  The Snail family of transcription factors consists of three members:  Snai1  
 
(Snail), Snai2 (Slug), and Snai3 (Smuc).  These proteins are conserved  
 
throughout evolution and share a high degree of protein sequence homology.   
 
While best known for roles in developmental biology and malignancy, members  
 
of the family (i.e., Snai2) have been shown to function in hematopoietic  
 
progenitor biology.  Additionally, the overlapping expression of Snail genes is  
 
evident in a multitude of hematopoietic cell types.  To test whether Snai2 and  
 
Snai3 functioned redundantly in hematopoiesis, germline double knockout  
 
animals were generated. 
  
Analysis of Snai2/Snai3 germline double knockouts demonstrated  
 
imbalances in the development of lymphoid and myeloid lineages, which  
 
absolutely required the deletion of both Snai2 and Snai3.  These animals were
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also affected nonhematopoietically as evidenced by the almost complete  
 
absence of female double knockout progeny and accelerated thymic atrophy.   
 
Furthermore, one allele of either Snai2 or Snai3 rescued all phenotypes to a  
 
similar degree suggesting that both gene products were haplo sufficient in the  
 
ability to compensate for the loss of the other three alleles.  
 
Snai2/3 conditional double knockout mice were generated in an effort to  
 
better ascertain the hematopoietic cell intrinsic roles of Snai2 and Snai3.  Snai2/3  
 
conditional double knockout animals expired at approximately one month of age  
 
due to rampant autoimmunity inclusive of both IgM and IgG autoantibodies.   
 
Adoptive transfer of wildtype regulatory T cells halted autoimmune pathology,  
 
autoantibody production, and rescued animals from death.  Importantly,  
 
autoimmunity was generated in Snai2 sufficient Rag2-/- animals receiving double  
 
knockout bone marrow.  These data supported a cell intrinsic role for Snai2 and  
 
Snai3 in regulating immune tolerance. 
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Snail Family Overview 
 
 The Snail family of transcriptional regulators is composed of three  
 
members: Snai1 (Snail), Snai2 (Slug), and Snai3 (Smuc) (1, 2).  Snai1 was first  
 
discovered in Drosophila melanogaster (3).  The other two family members (i.e.,  
 
Snai2 and Snai3) are thought to have arisen in metazoan evolution via gene  
 
duplication events (4, 5).  As a result, all three family members are present in the  
 
genomes of mouse and man. 
  
 Snail proteins consist of two main functional domains.  The N-terminus of  
 
all three proteins contains a SNAG (Snail and Gfi-1) domain, which is essential in  
 
the recruitment of chromatin modifiers such as histone deacetylases (HDACs)  
 
and histone methyl transferases (HMTs) (6-8).  In the C-terminus, each protein  
 
contains a variable number of C2H2 zinc finger DNA-binding domains (DBDs)  
 
(four for Snai1, five for Snai2 and Snai3) (2).  These DBDs recognize and bind to  
 
canonical E-box motifs (CANNTG).  In particular, Snail proteins bind  
 
to E-box motifs enriched for G/C-rich central dinucleotides suggesting at least  
 
some level of binding site specificity (9, 10).  Through these domains, Snail  
 
proteins act to modulate target genes, most notably in a repressive fashion (11).    
 
 
The Snail Family in Development and Cancer 
 
Although not the focus of this dissertation, it is important to provide an  
 
overview of how Snail proteins play a role not only in development, but also  
 
cancer progression.  Over the years, these proteins have been studied in a wide  
 
variety of invertebrate and vertebrate systems.  For the sake of brevity, only work  
 
that utilized models of mouse and man will be discussed in detail.   
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 Snail proteins are best known for their roles in a multitude of  
 
developmental processes.  The function of this family in mouse development  
 
begins at the pre-implantation stage of embryonic development.  Both Snai1 and  
 
Snai2 proteins are expressed at the one-cell (zygote), two-cell, four-cell, eight- 
 
cell, compacted, and blastocyst stages (12).  Examination of these stages, in  
 
particular at the earliest cleavage events, demonstrated an almost random  
 
pattern of protein distributed among daughter cells perhaps suggesting a  
 
stochastic inheritance of pre-existing protein among cellular progeny.   
 
Interestingly, Galvagni et al. has since shown that embryonic stem cells (ESCs)  
 
(derived from the inner cell mass) can be induced to express Snai1 via retinoic  
 
acid (normally derived from the trophectoderm) (13).  This was specific to Snai1  
 
as Snai2, Snai3, and other epithelial-to-mesenchymal transition (EMT) factors  
 
such as Twist were unaffected.  Furthermore, forced overexpression of Snai1 led  
 
to the premature differentiation of ESCs into all three germ layers.    
 
Mechanistically, Snai1 repressed a multitude of target genes previously  
 
characterized as promoters of self-renewal.  Some of these targets included  
 
Nanog, Klf4 and Essrb (a direct Nanog target) (13, 14).  It has been known for  
 
some time that Snai1 germline knockout mice die by embryonic day 8.5 (E8.5)  
 
due to gastrulation defects. This has mainly been attributed to defective  
 
mesoderm migration as a result of continued Cdh1 (E-cadherin) expression (15).   
 
Perhaps less appreciated was the dysregulated expression of various germ layer  
 
“markers” such as Otx2, normally expressed in the visceral endoderm and  
 




maintenance of proper germ layer differentiation independent of a cellular  
 
migration context.  As a continuum of this work, the laboratory of Thomas Gridley  
 
conditionally deleted Snai1 in the embryo using a Meox2-driven Cre (16, 17).   
 
Similar to the germline deletion of Snai1, these animals were also embryonic  
 
lethal.  However, mortality was seen at E9.5 due to the inability to form complex  
 
vascular networks in accord with enhanced formation of endothelial cell  
 
aggregates (16).  Additionally, left-right asymmetry and neural crest migration  
 
were also examined in these mice (17).  Similar to its role in avian species, Snai1  
 
was required for proper left-right asymmetry in mice (18, 19).  Both model  
 
systems demonstrated similar phenotypes including aberrant heart looping and  
 
the upregulation of Nodal and Pitx2 on the right side of the body.  This  
 
demonstrated that similar to the role of Snai1 in gastrulation, the function of  
 
Snai1 in left-right asymmetry had also been evolutionarily conserved.  In  
 
contrasting fashion, Snai1 and Snai2 were both dispensable for proper neural  
 
crest formation in these mice (17).  This diverged from results in both Xenopus  
 
laevis and avian model systems.  This may suggest a redundant role for Snai3  
 
or possibly a Snail-independent program of neural crest formation in  
 
mice (20, 21).     
  
Snai2 is widely expressed in the organs of the developing embryo (22).   
 
However, Snai2 germline knockout animals display relatively minor phenotypes.   
 
One of the tissues with the highest expression of Snai2 is the skin (23, 24).   
 
Detection of Snai2 expression can be found in the mouse epidermis as soon as  
 




show retarded kinetics in hair growth; however, they are undistinguishable from  
 
wildtype animals by adulthood.  Of more interest, Snai2 has been shown to be a  
 
critical mediator of keratinocyte re-epithelialization following cutaneous wounding  
 
suggestive of a more critical role for Snai2 in stress related responses (23).  As  
 
might be expected, this was due to the repression of cell-cell junctions by Snai2,  
 
a well known mediator of EMT (25).  Switching focus slightly, it has been  
 
observed that Snai2-/- animals demonstrate a slight growth deficiency within the  
 
pre-weaning period.  In accordance with this phenotype, Snai2 deficient mice  
 
also displayed a significant loss of white adipose tissue (WAT) (26).  This  
 
phenotype was not due to activity differences between wildtype and knockout  
 
strains.  Rather reduction of WAT was attributed to the loss of Pparg2  
 
expression, a key driver of adipogenesis (27).  Perhaps most noteworthy, in vitro  
 
analysis showed that Snai2 synergized with C/EBPα, and to a lesser extent  
 
C/EBPβ, in promoting Pparg2 expression.  Currently unknown is whether these  
 
factors directly interact.  In rare instances of direct gene induction, Snai1 has  
 
been shown to interact with partners such as EGR-1, SP-1, and Nanog (28, 29).   
 
In total, this work points to much more dynamic roles for Snai1 and Snai2  
 
proteins beyond that of “obligate gene repressors.”  Perhaps the most profound  
 
phenotypes of Snai2-/- deficient mice revolve around reproduction, a hormonally  
 
driven process like adipogenesis.  Snai2-/- female mice display reduced  
 
mammary gland formation due to a combination of decreased proliferation and  
 
increased differentiation of mammary basal epithelial cells (30).  This  
 




for Snai2 expression in comparison to luminal epithelial cells (i.e., differentiated  
 
epithelium).  Using CommaDβ cells, a breast cancer cell line, it was found that  
 
enforced overexpression of Snai2 increased mammosphere growth (a measure  
 
of stemness) via increased cell proliferation (Ki67+ cells) and decreased  
 
apoptosis (Caspase-3+ cells) (30).  From the male perspective, mice deficient in  
 
Snai2 have diminished fertility due to testicular defects that include a reduction in  
 
seminiferous tubules and Leydig cells, both of which are critical for  
 
spermatogenesis (31).  The reason for these defects is currently unknown.  Both  
 
the male and female reproductive phenotypes are relatively modest in magnitude  
 
(i.e., mammary glands and sperm still ultimately developed).  In Snai2-/-  
 
mammary glands, Snai3 is upregulated approximately five fold at five weeks and  
 
eight fold by ten weeks postbirth suggestive of potential compensation among  
 
Snail members (30).  Surprisingly, this was specific to Snai3, as Snai1  
 
expression was not enhanced in Snai2-/- mammary glands.  This may be  
 
indicative of unique regulatory mechanisms for the control of Snai3 expression.   
 
This is not completely unheard of as Snai1 and Snai2 can be differentially  
 
regulated via TGFβ and Notch in certain cellular contexts (32).    
  
 Currently, the literature regarding the developmental roles of Snai3 is quite  
 
limited.  In fact, Snai3 germline knockouts have no apparent developmental  
 
phenotypes (33-35).  However, use of the in vitro C2C12 myoblast differentiation  
 
system has demonstrated the potential for Snai3 to repress muscle  
 
differentiation.  Using an electromobility shift assay (EMSA), Snai3 was shown to  
 




and Snai2 are also capable of blocking MyoD-driven differentiation of muscle  
 
(10).  Collectively, this work provides a potential explanation for the lack of 
 
Snai3-/- phenotypes: Snail family redundancy. 
  
As summarized above, the Snail family plays significant roles in  
 
development.  As such, it is not surprising that this family also contributes to the  
 
progression of various malignancies inclusive of processes such as EMT and de- 
 
differentiation (36).  Snai1 and Snai2 have been studied extensively in cancer.   
 
However, only recently has Snai3 gained attention in this regard (37).  Gras et al.  
 
demonstrated that Snai3 was overexpressed in samples from multiple breast  
 
cancer subsets.  Overexpression of the Snail proteins in breast cancer cell lines  
 
suggested that Snai3 was a relatively inefficient driver of EMT when compared to  
 
both Snai1 and Snai2.  Interestingly, Snail proteins were able to repress a largely  
 
overlapping gene set; however, Snai3 did this at a lower magnitude (37).  Why  
 
Snai3 was as ineffective as Snai1 and Snai2 is unknown.  Perhaps Snai3 recruits  
 
a differential set of chromatin modifiers that were poorly expressed in these  
 
particular cell lines.  Alternatively Snai3 may not bind E-boxes with the same  
 
affinity as Snai1 and Snai2.  Snail-driven EMT is crucial for cancer progression;  
 
however, the activity of Snail proteins is not limited to this process (11).  Perhaps  
 
the most therapeutically relevant is the ability of Snail proteins to block apoptosis  
 
in response to external stress.  Kim et al. showed that Snai2 promoted the  
 
survival of breast cancer cells during lung metastasis through the direct  
 
repression of Puma (38).  Additionally, Snai2 overexpression was protective from  
 




Snai2 were sensitized to cell death; however, this effect was reversed upon the  
 
concomitant knockdown of Puma (38).  In a separate report, Snai2 decreased  
 
radiosensitivity of melanoma cells also through the repression of Puma (39).   
 
Clearly, this contribution of Snail members to cancer biology requires further  
 
investigation.  Overall, Snail proteins are key mediators of cancer  
 
progression/metastasis but may also be essential in determining therapeutic  
 
resistance.                   
 
 
The Snail Family in Hematopoiesis 
 
At this time, there are no data addressing the role of Snai1 within the  
 
hematopoietic system.  Recently, we have generated a hematopoietic-specific  
 
deletion of Snai1 via utilization of the Vav-Cre deleter strain and a strain  
 
possessing a conditionally targeted Snai1 gene.  Unlike the case in  
 
embryogenesis, Snai1 is not required for hematopoiesis since these conditional  
 
Snai1-deleted mice are viable, outwardly healthy, and present no obvious  
 
hematopoietic deficiencies (Pioli et al. unpublished data).  
 
While the importance of Snai1 in hematopoiesis may be a nascent field,  
 
Snai2 has been studied in this context for over a decade.  An initial report by  
 
Inukai et al. demonstrated overexpression of Snai2 in several human B cell  
 
leukemia cell lines.  Upregulation of Snai2 was dependent upon the E2A-HLF  
 
oncoprotein generated from a t(17;19) chromosomal translocation.  Usage of the  
 
murine IL-3 dependent Baf3 Pro-B cell line demonstrated that overexpression of  
 
Snai2 was sufficient to confer resistance to apoptosis induced by growth factor  
 
withdrawal which was accompanied by exit from the cell cycle (40).  In regards to  
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cancer progression, Snai2 and Snai1 are most commonly identified for their  
 
ability to augment solid tumor phenotypes.  This result suggested a potential role  
 
for these proteins in regards to hematological cancers. Interestingly, Perez- 
 
Losada et al. demonstrated the ability of c-Kit signaling to induce Snai2  
 
expression.  In vitro studies utilized both Baf3 and LAMA-84 cells overexpressing  
 
c-Kit.  Of note, LAMA-84 cells were originally derived from a chronic myeloid  
 
leukemia (CML) patient undergoing blast crisis (41).  The mechanism of Snai2  
 
upregulation becomes relevant when one considers that c-Kit is highly expressed  
 
on the surface of acute myeloid leukemia (AML) cells (42, 43).  A later study by  
 
Mancini et al. demonstrated enhanced levels of Snai2 in CML patients.   
 
Depletion of Snai2 via siRNA increased sample sensitivity to apoptosis as these  
 
cells lost expression of Bcl-xL (anti-apoptotic) and increased levels of Puma (pro- 
 
apoptotic) (44).  In this instance, Snai2 expression appeared to be driven by  
 
BCR-ABL signaling as Imatinib treatment decreased Snai2 levels.  These data  
 




Moving forward, the point of emphasis shifts towards the role of Snai2 in  
 
more physiologic hematopoietic settings.  Included within the Perez-Losada et al. 
 
report was an initial description of hematopoiesis in the Snai2 knockout mouse.   
 
They observed multiple defects, which mainly focused on erythropoiesis (31).   
 
Complete blood counts showed a trend towards lower erythroid “output.”  Using  
 
in vivo models of phenylhydrazine (PHZ)- and pregnancy-induced anemia, a  
 




role for Snai2 in hematopoietic stress responses and its requirement in  
 
reconstituting the erythroid lineage.  Intriguingly, Snai2+/- animals showed similar  
 
defects as the Snai2-/- suggesting a gene dosage component.  Examination of  
 
steady state hematopoiesis did not show any deviation from normal myeloid and  
 
B cell generation.  However, a decreased ratio of developing CD4 and CD8  
 
double positive thymocytes was observed in Snai2 knockout animals.  This was  
 
apparently a result of increased apoptosis as indicated by terminal  
 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining of  
 
thymic cross-sections.  Almost immediately following this publication, a separate  
 
study from the Look lab showed the expression of Snai2 in multiple bone marrow  
 
progenitor lineages including the hematopoietic stem cell (HSC) (long-term  
 
(HSC-LT) and short-term (HSC-ST)), common lymphoid (CLP), and common  
 
myeloid (CMP) progenitors among others.  Colony forming assays were  
 
performed to evaluate differentiation potential of progenitors in the bone marrow  
 
and spleen.  While the Snai2-/- progenitors trended towards an increase in colony  
 
forming units (CFUs) for various lineages, no clear-cut enhancement over  
 
wildtype (WT) was observed.  Expanding on this, they assayed the ability of  
 
Snai2-/- animals to reconstitute the hematopoietic compartment following an LD50  
 
dose of total body irradiation (TBI), also a stress response (45).  By thirteen days  
 
post-irradiation, all Snai2-/- animals had died due to pancytopenia.  This was in  
 
stark contrast to both WT and Snai2+/- animals in which approximately fifty  
 
percent survival was achieved when followed out to twenty-nine days.  Closer  
 




Snai2-/- lineage negative (Lin-) bone marrow leading to the pancytopenia.  As  
 
such, administration of a thrombopoietin analog rescued irradiation-induced  
 
lethality of Snai2-/- animals.  Using bone marrow chimeras, a follow up study  
 
demonstrated that loss of Snai2 in the hematopoietic compartment was sufficient  
 
to propagate the irradiation phenotype described above (46).  Importantly, WT  
 
bone marrow administered to irradiated Snai2-/- hosts completely prevented any  
 
lethality providing further evidence for a cell intrinsic role for Snai2 in  
 
hematopoiesis.  Using a well-designed combination of knockout and transgenic  
 
animals, it was shown that Snai2 functioned downstream of p53 to block the  
 
activation of Puma.  This was accomplished via a direct E-box interaction within  
 
intron one of the Puma gene.  Similar to previously discussed data, this effect  
 
was specific to Puma as Snai2-/- Puma-/- compound knockout animals were  
 
completely radio-resistant (46).  If other apoptotic mediators were playing a role,  
 
an intermediate phenotype would have been expected.  Finally, a group led by  
 
Wen-Shu Wu examined the self-renewal capacity of hematopoietic stem cells  
 
with and without Snai2 (47).  Using limiting dilution bone marrow chimera  
 
transplants, it was determined that Snai2-/- marrow possessed an approximately  
 
eight-fold higher repopulation efficiency as compared to Snai2+/-.  Competitive  
 
serial transplantation, a gold standard for assessing hematopoietic stem cell  
 
(HSC) fidelity, further demonstrated the enhanced ability of the Snai2-/- HSC to  
 
reconstitute the entire hematopoietic system.  Incorporation of 5-ethynyl-2’- 
 
deoxyuridine (Edu) combined with Annexin V cell surface staining demonstrated  
 




augmented apoptosis within the Snai2-/- Lin- Sca1+ compartment.  This result  
 
coalesces with the previously identified ability of Snai2 overexpression to induce  
 
cell cycle exit by Baf3 cells (40).  While the molecular targets of Snai2 were not  
 
identified, they may be similar to what has been previously observed for Snai1.   
 
In a nontumorigenic context, Snai1 is able to inhibit the cell cycle of MDCK cells  
 
by repressing cyclin D2 at the transcriptional level (48).  In a noncanonical role  
 
for the Snail family, it was also reported that Snai1 co-associated with EGR-1  
 
and SP-1 to upregulate p15INK4b, leading to the arrest of HepG2 cells (29). 
 
The function of the Snai3 transcriptional regulator in the hematopoietic  
 
system was first analyzed in an indirect investigation, the analysis of proteins  
 
binding to negative regulator elements of the murine Itgb2l (Pactolus) gene (49).   
 
Using a combination of EMSA and supershift assays, it was shown that Snai3  
 
was capable of binding to these transcriptional regulatory sites.  The most  
 
intriguing aspect of this work was the hypothesis that in scenarios where diverse  
 
cell types, such as B cells and neutrophils, express a common transcriptional  
 
activator (e.g., PU.1), differential expression of a negative regulator may  
 
potentially augment lineage specific expression of downstream genes.  Thinking  
 
more globally, Dahlem et al. asked whether retroviral-induced overexpression of  
 
Snai3 in a bone marrow chimera model was capable of augmenting  
 
hematopoiesis.  Using c-Kit and Sca-1 based analysis of lineage depleted  
 
marrow, it was determined that overexpression of Snai3 did not alter ratios of  
 
various subsets of hematopoietic progenitors (50).  However, inspection of  
 




were infected with the Snai3-expressing retrovirus (as assayed by GFP  
 
expression).  This effect was dose dependent as B and T cell populations were  
 
present when Snai3 overexpression was at a modest amount (GFP low).   
 
Importantly, B and T cells were present when the empty vector was expressed at  
 
both low and high levels, arguing against any retroviral-induced artifacts.  These  
 
data suggested that Snai3 was either capable of saturating endogenous E-boxes  
 
necessary for the proper bifurcation of lymphoid and myeloid lineages or directly  
 
repressing gene expression by the recruitment of transcriptional control  
 
complexes.  These data also alluded to a requirement for precise regulation of  
 
Snai3 within the hematopoietic system. 
 
 
Redundancy Among Snail Family Members   
 
 There is plenty of evidence to suggest that Snail family members are  
 
capable of compensating for the absence of one another.  This includes a limited  
 
number of single knockout phenotypes, overlapping patterns of gene expression,  
 
upregulation of one family member when another is removed, and the regulation  
 
of overlapping gene sets when each member is singly overexpressed (see  
 
above).  However, the best evidence is derived through genetic models of multi- 
 
gene knockouts (35, 51, 52).  Murray et al. were the first to provide genetic  
 
evidence of a functional redundancy between Snail family members (52).   
 
Analysis of Snai2-/- neonates demonstrated an approximately fifty percent  
 
penetrance of cleft palate.  However, Snai1+/- Snai2-/- presented with a one- 
 
hundred percent penetrance of this disorder.  While Snai1 was able to  
 
compensate for Snai2, this relationship was susceptible to gene dosage.  Not  
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surprisingly, wildtype animals showed overlapping expression of Snai1 and Snai2  
 
in the palatal mesenchyme at E14.5.  Furthermore, the use of a Snai2lacZ reporter  
 
demonstrated enhanced expression of Snai2 in a Snai1+/- background.  In  
 
another report from the Gridley lab, Snai1 and Snai2 functioned in a  
 
compensatory manner to preserve chondrogenesis and long bone development  
 
(51).  Conditional deletion of Snai1 via Prrx1-Cre combined with a Snai2 germline  
 
deficiency resulted in shortening of the long bones.  This was attributed to not  
 
only the loss of proper chondrocyte organization during development, but also  
 
decreased chondrocyte proliferation due to aberrant expression of cell cycle  
 
inhibitors (i.e., Cdkn1a).  Not only was Snai1 overexpressed in the absence of  
 
Snai2 and vice versa, but these genes were also expressed in cell types normally  
 
dormant for their expression.  This was later attributed to the ability of Snai1 and  
 
Snai2 to directly antagonize the expression of one another (53).  As an extension  
 
of this, we asked whether Snai2 and Snai3 might function redundantly to  
 
augment hematopoiesis.  The reasons we focused on these two family members  
 
are as follows: overlapping expression in various hematopoietic lineages,  
 
published hematopoietic phenotypes, and Snai1 was difficult to work with given  
 
the issue of embryonic lethality of the germline deleted animal.   
 
Chapter two describes the generation and analysis of a Snai2/Snai3  
 
germline double knockout animal (35).  Snai2/Snai3 germline double knockouts  
 
possessed multiple hematopoietic and nonhematopoietic phenotypes, all of  
 
them greater than that found in the single Snai2-/- or Snai3-/- animals.  These  
 




towards the generation of the male sex.  Additionally, lymphoid organs such as  
 
spleens and thymi were significantly reduced in size and possessed distorted  
 
cellular organization/localization.  The most striking hematopoietic phenotype of  
 
the double knockouts was the enhanced ratio of myeloid lineage-derived cells in  
 
the bone marrow.  This was met with a concomitant reduction of B cell  
 
percentages.   In the thymus of Snai2-/- Snai3-/- mice, double positive thymocytes  
 
were reduced in favor of enhanced percentages of CD4 single positive  
 
thymocytes.  Unlike in the marrow, skewing of thymocyte populations displayed  
 
variable penetrance perhaps due to the presence of intact Snai1 alleles.   
 
Analysis of compound heterozygotes suggested that on a per allele basis, one  
 




Due to the nonhematopoietic phenotypes evident in the germline double  
 
knockout, it was necessary to evaluate the roles of Snai2 and Snai3 in a more  
 
hematopoietically-restricted context.  Chapter three details the generation and  
 
analysis of a “conditional” Snai2/Snai3 double knockout.  These animals  
 
displayed severe lymphopenia, alopecia, and dermatitis as well as profound  
 
autoimmunity manifested by the production of high levels of autoantibodies as  
 
early as three weeks of age.  This led to death by thirty days after birth.   
 
Autoantibodies included both IgM and IgG isotypes and were reactive against  
 
cytoplasmic and membranous components.  A regulatory T cell defect  
 
contributed to the autoimmune response in that adoptive transfer of wildtype  
 




transplantation of Snai2/Snai3 double knockout bone marrow into Snai2 sufficient  
 
Rag2-/- recipients resulted in autoantibody generation.  The results demonstrated  
 
that appropriate expression of Snai2 and Snai3 in cells of hematopoietic  
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 This dissertation details novel contributions of Snai2 and Snai3 in  
 
hematopoietic biology.  Overall, Snai2 and Snai3 functioned redundantly to  
 
preserve the development and function of lymphocytes as the conditional  
 
deletion of both genes led to lymphopenia and autoimmunity.  Importantly,  
 
autoimmunity was still generated when Snai2/Snai3 double knockout bone  
 
marrow was transplanted into Rag2-/- Snai2+/+ animals.  This supported a cell  
 
intrinsic role for these regulators in immune tolerance.  However, some  
 
interesting questions remain.  Why does the Snai2/Snai3 conditional double  
 
knockout (cDKO) develop autoimmunity but the germline double knockout  
 
(gDKO) does not?  What are the individual contributions of various cell types to  
 
autoimmunity?  What are the transcriptional targets of Snai2 and Snai3 in these  
 
cell types?  Finally, does Snai1 play a role in the immune system?   
 
 
No Autoimmunity in the Germline Double Knockout 
 
 From an immunological standpoint, the most interesting contrast between  
 
the Snai2/Snai3 double knockout models was the apparent lack of autoimmunity  
 
in the gDKO.  This result was supported by a lack of alopecia and inflammation,  
 
a lifespan of up to six months of age, and the lack of autoantibody generation in  
 
the germline deleted mice.  Perhaps overly simplistic, one explanation may be  
 
the general epigenetic upregulation of Snai1 due to the global loss of four Snail  
 
alleles (i.e., Snai2 and Snai3 in the gDKO).  While no data currently support this  
 
notion, the hypothesis would be testable via the introduction of a Snai1  
 
conditional allele which could be specifically deleted via a Vav-Cre transgene.  If  
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this really is a question of gene dosage, then deletion of one Snai1 allele would  
 
be predicted to result in the induction of autoimmunity.   
 
An alternative hypothesis is that Snai3 has functional roles in the  
 
stromal compartment in regard to promoting an immune response.  As above,  
 
this is another very testable hypothesis.  One could simply introduce an inducible  
 
Cre such as Mx1-Cre into the already existing conditional double knockout that  
 
normally deletes Snai3 only in the hematopoietic system (1).  If stromal  
 
expression of Snai3 is crucial for autoimmunity, the administration of poly(I:C)  
 
and subsequent stromal deletion of Snai3 would be “curative” for cDKO mice.   
 
Given that this is an interferon-inducible system, “leaky” expression may occur as  
 
disease progresses in the cDKO.  As such, an alternative inducible system would  
 
be required (e.g., Doxycycline-inducible).  However, if this scenario is true then  
 
how does Snai3 function in the stroma to regulate an immune response? 
 
 Given the history of Snail proteins, the most likely contribution may be in  
 
immune cell migration and localization.  The Immunological Genome Project  
 
(ImmGen) has collected data from multiple cell types including stromal cells from  
 
secondary lymphoid organs.  Analysis of fibroblastic reticular cells has  
 
demonstrated a significant level of Snai3 expression.  These cells are key  
 
determinants of secondary lymphoid structure and immune function through the  
 
expression of various chemokines such as CXCL12, CCL19, and CCL21 (2-4).   
 
Interestingly enough, these cytokines can induce Snail expression through  
 
CXCR4 and CCR7 signaling setting the stage for a stromal/hematopoietic  
 




Snai3 is also a repressor of E-cadherin (7).  Keratinocytes in the mouse dermis  
 
express E-cadherin.  The inappropriate expression of E-cadherin would thus  
 
result in the sequestration and tolerization of Langerhans cells (LC), a  
 
specialized dendritic cell subset (8).  Mechanistically, this occurs through  
 
homotypic interactions with LC-expressed E-cadherin (9).  Additional work has  
 
since shown that crosslinking of β-catenin by E-cadherin induces a toleragenic  
 
state in dendritic cells through the blockade of costimulatory molecules such as  
 
B7 (10).  Considering these data, it becomes easy to see how the stromal  
 
deletion of Snai3 on top of the loss of Snai2 would potentiate an  
 
immunosuppressive environment.        
 
 
Contributing Cell Types and Gene Targets 
 
 Snai2/Snai3 conditional double knockout mice develop a fatal  
 
autoimmunity that includes both IgM and IgG isotypes.  This suggests a loss of  
 
both B and T cell tolerance.  Additionally, these phenotypes were reversible upon  
 
the adoptive transfer of wildtype regulatory T cells (TRegs) indicative of a cDKO  
 
TReg defect.  Unlike Rag2-/- recipients, wildtype animals that received cDKO bone  
 
marrow did not develop autoimmunity due to residual radioresistant TRegs.  PCR- 
 
based genotyping of cell populations demonstrated that approximately seventy- 
 
five percent of conventional T cells (TConv) were derived from cDKO bone marrow  
 
(Pioli et al. unpublished data).  In stark contrast, only roughly twenty-five percent  
 
of TRegs were derived from cDKO donor cells.  These data further support the  
 
idea that cDKO TRegs are defective compared to their wildtype counterparts.   
 
Currently, these experiments are being repeated with Ubc-GFP mice.  This will  
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allow for a more accurate quantification of donor cell contribution as the source of  
 
TRegs (CD4+ CD25+) can be identified by GFP expression.  More importantly,  
 
cDKO TRegs can be isolated for the purpose of transcriptional profiling using RNA  
 
sequencing (RNA-Seq).  These experiments will be fundamental in  
 
understanding how the loss of Snai2 and Snai3 affects the TReg transcriptional  
 
program and thus, cellular function.  
 
 Our initial evaluation of cDKO mice demonstrated a propensity to generate  
 
autoantibodies that targeted cell surface antigens.  This suggested impaired B  
 
cell central tolerance as B cells would normally be expected to undergo negative  
 
selection.  This would prevent peripheral recognition of surface exposed self- 
 
antigens and the induction of autoimmunity.  Rather interestingly, transplant of  
 
cDKO marrow into Rag2-/- animals that had intact Snai2 alleles demonstrated a  
 
shift in autoantibody reactivity.  These animals generated a high level of  
 
autoantibodies that recognized intracellular self-antigens but with almost a  
 
complete absence of reactivity to surface antigens.  Since these animals still  
 
possessed Snai2, the results suggested that deletion of Snai2 might have led to  
 
inappropriate expression of self-antigens in the periphery thus shifting the  
 
autoantibody repertoire.  Additionally, recipients of cDKO marrow did not die due  
 
to disease by nine weeks posttransplant.  This result is indicative of a limited  
 
scope (or progression) of disease; an interpretation supported by the  
 
autoantibody data.  Additionally, the germline deletion of Snai2 (an anti-apoptotic  
 
gene) may sensitize mice to cell death as a result of autoimmune-induced  
 




a disease accelerator rather than an initiator.  It is important to note that we were  
 
not able to compare the transplantation of cDKO bone marrow into both Rag2-/-  
 
and Rag2-/- Snai2-/- mice so it impossible to draw too firm of conclusions in  
 
regards to the differences between the intact, or “whole” cDKO and Rag2-/-  
 
recipients receiving cDKO bone marrow.  Further studies will be needed to fully  
 
assess these questions.               
 
 Given all this, it becomes tempting to speculate that TRegs are the only  
 
hematopoietic cells intrinsically responsible for cDKO autoimmunity.  Although  
 
not readily appreciated, TRegs are important mediators of peripheral B cell  
 
tolerance as well as that of T cells (11, 12).  Importantly, cDKO B cells were  
 
ultimately susceptible to regulation by wildtype regulatory T cells.  One way to  
 
assess this question will be to generate strains that delete Snai3 just in TRegs (i.e.,  
 
Foxp3-Cre) and delete Snai3 in both TRegs and B cells (i.e., Foxp3-Cre and Mb-1- 
 
Cre combined).  If both strains demonstrate similar disease severity, then it can  
 
be concluded that TReg dysfunction is the essential, and main, component of the  
 
Snai2/Snai3 cDKO autoimmune model.  Similar types of comparisons can be  
 
made using alternatives such as Cd4-Cre to specifically delete Snai3 in T cells  
 
while leaving the B cell compartment intact.      
 
 
Snai1 in Hematopoiesis 
 
The body of work presented here has focused on Snai2 and Snai3.   
 
However, the role of Snai1 in hematopoiesis is unknown.  Current work in our lab  
 
has demonstrated that the conditional deletion of Snai1 via Vav-Cre (1cKO) has  
 
very few consequences at steady state.  Perhaps this is not surprising given the  
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overlapping expression pattern of Snai1 and Snai3 in both B and T cells (Chapter  
 
3) (13).  As such, the effort to generate and characterize Snai1/Snai3 conditional  
 
double knockout mice is underway. 
 
Still, maybe a lack of Snai1 cKO phenotypes is not due to redundancy.   
 
Rather, Snai1 may play a subtler role that requires the system under study to be  
 
stressed before a phenotype is evident.  Snai1 is a critical mediator of  
 
differentiation during early embryonic stem cell differentiation (14).  Previous  
 
work in the immune system has shown a crucial role for Snai2 as a progenitor  
 
stress “response” gene (15, 16).  So does Snai1 play a similar role in  
 
hematopoietic stem cells (HSCs)?  HSCs require strict control of programs  
 
driving self-renewal and differentiation in order to properly respond to cellular  
 
demands such as infection while also maintaining a long-term progenitor pool  
 
(17, 18).  As such, it is appropriate to analyze this potential function for Snai1  
 
under conditions of stress.  This can be done by the administration of sublethal  
 
doses of irradiation or the provision of 5-fluorouracil (5-FU), both of which would  
 
induce the need to replenish blood cells.  From there, one can assay the ability of  
 
Snai1 cKO mice to reconstitute various lineages while also maintaining a long- 
 
term HSC pool.  These assays mainly focus on progenitor biology.  However, it is  
 
important to consider how Snai1 might function in mature lineages. 
 
Transcriptional profiling suggests that Snai1 may play a role in mature  
 
lymphocyte populations.  Recently, it has been shown that NR2F6 is a key  
 
repressor of T helper 17 (TH17) cell differentiation (19, 20).  Biochemical analysis  
 




phosphorylation.  Of interest, pathways induced by T cell receptor signaling such  
 
as AKT and ERK signaling have been shown to induce Snai1 in other model  
 
systems (5, 21).  Additionally, it has been shown that Snai1 negatively regulates  
 
adipocyte differentiation through the direct repression of Nr2f6 (22).  This leads  
 
one to speculate that Snai1 may be upregulated in TH17 cells in order to  
 
suppress Nr2f6 at the gene level, essentially creating a TH17 feed forward loop.   
 
This becomes more reasonable when one considers the fact that IL-17 induces  
 
Snai1 expression in multiple myeloma (23).  Whatever the roles of Snai1 turn out  
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